Management of GI Bleeding with Severe Anemia in a 53-Year-Old Male Post-Colostomy
This patient requires urgent gastroenterology consultation, intravenous iron supplementation instead of oral iron, and comprehensive GI workup to identify the source of bleeding causing his severe iron deficiency anemia.
Initial Assessment and Management
Laboratory Evaluation
- STAT CBC confirms severe microcytic, hypochromic anemia (Hb 7.1 g/dL) consistent with iron deficiency
- Additional labs needed immediately:
- Iron studies (serum iron, TIBC, ferritin, transferrin saturation)
- Coagulation profile (PT/INR, PTT)
- Type and screen for potential blood products
Immediate Management
Iron Supplementation
Blood Transfusion Consideration
Diagnostic Workup
Urgent GI Consultation
- Expedite GI consultation as recommended in ED discharge
- Recent colostomy placement (2 days ago) requires surgical assessment for potential bleeding at surgical site
Endoscopic Evaluation
- Both upper and lower GI investigations should be performed in male patients with confirmed iron deficiency anemia 1
- Gastroscopy and colonoscopy should be the first-line GI investigations 1
- Timing: Endoscopy should be performed within 24 hours for acute bleeding 3
Additional Testing
- Screen for celiac disease as recommended for all patients with IDA 1
- If initial endoscopic evaluation is negative, consider small bowel evaluation with capsule endoscopy 1
- CT enterography may be considered if capsule endoscopy is contraindicated 1
Long-term Management
Iron Replacement Therapy
- Continue IV iron until hemoglobin normalizes
- After normalization, continue treatment for approximately 3 months to replenish iron stores 1
- Monitor hemoglobin response within 4 weeks of initiating therapy 1
Follow-up
- Repeat CBC in 2-4 weeks to assess response to therapy
- If hemoglobin fails to rise appropriately despite IV iron, further investigation is warranted 1
- Long-term iron therapy may be necessary if the cause of recurrent IDA is irreversible 1
Special Considerations
Medication Management
- Avoid NSAIDs as they are common causes of GI bleeding and IDA 1
- If oral iron is eventually reintroduced:
Common Pitfalls to Avoid
- Inadequate investigation: Studies show up to 80% of patients are discharged with anemia after GI bleeding with less than 20% receiving appropriate iron supplementation 5, 6
- Focusing only on transfusion: Blood transfusions do not correct the underlying pathology and have no lasting effect 1
- Delaying iron therapy: Iron replacement should not be deferred while awaiting investigations 1
- Missing dual pathology: The presence of significant bleeding sources in both upper and lower GI tracts occurs in 1-10% of patients 1
This comprehensive approach addresses both the immediate management of severe anemia and the systematic investigation of the underlying GI bleeding source, which is essential for improving this patient's morbidity, mortality, and quality of life outcomes.